COVID-19 vaccination and immune thrombocytopenia
- 9 June 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (7), 1145-1146
- https://doi.org/10.1038/s41591-021-01419-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic ThrombocytopeniaThe New England Journal of Medicine, 2021
- First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandNature Medicine, 2021
- Prothrombotic immune thrombocytopenia after COVID-19 vaccinationBlood, 2021
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort studyThe Lancet, 2021
- Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITPBlood Advances, 2021
- Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national dataBMJ Open, 2020
- Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP RegistryBlood Advances, 2017
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in FranceBlood, 2014
- Thrombocytopenic Purpura after Measles-Mumps-Rubella Vaccination: A Systematic Review of the Literature and Guidance for ManagementThe Journal of Pediatrics, 2010
- Effect of Live Measles Vaccine on the Platelet CountThe New England Journal of Medicine, 1966